These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3492137)
1. Leu 7+, Leu 11a- acute T-lymphoblastic leukemia having low K cell activity and no NK cell activity. Falcão RP; Ismael SJ Am J Hematol; 1987 Jan; 24(1):101-5. PubMed ID: 3492137 [TBL] [Abstract][Full Text] [Related]
2. T-cell acute lymphoblastic leukemia with natural killer cell phenotype. Kaplan J; Ravindranath Y; Inoue S Am J Hematol; 1986 Aug; 22(4):355-64. PubMed ID: 3487974 [TBL] [Abstract][Full Text] [Related]
3. An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subset. Moss VE; Miedema F; Matutes E; Terpstra F; Brownell A; Brozovic M; Catovsky D Clin Exp Immunol; 1986 Feb; 63(2):303-11. PubMed ID: 3486061 [TBL] [Abstract][Full Text] [Related]
5. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55. Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266 [TBL] [Abstract][Full Text] [Related]
6. Acute leukemia of hybrid phenotype: T lymphoid and myelomonocytic markers. González M; Alvarez de Mon M; San Miguel JF; Casas J; Durantez A; López Borrasca A Clin Immunol Immunopathol; 1985 May; 35(2):139-45. PubMed ID: 3878245 [TBL] [Abstract][Full Text] [Related]
7. Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Sheibani K; Winberg CD; Burke JS; Nathwani BN; Blayney DW; Van de Velde S; Swartz WG; Rappaport H Leuk Res; 1987; 11(4):371-7. PubMed ID: 3104695 [TBL] [Abstract][Full Text] [Related]
8. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799 [TBL] [Abstract][Full Text] [Related]
9. Functional and phenotypic analysis of a T cell prolymphocytic leukemia. Woods GM; Sawyer PJ; Kirov SM; Lowenthal RM; Jupe DM; Catovsky D Leuk Res; 1985; 9(5):587-96. PubMed ID: 3159942 [TBL] [Abstract][Full Text] [Related]
11. Childhood acute lymphoblastic leukemia with natural killer activity. Clinical and cellular features of three cases. Komiyama A; Yamada S; Kawai H; Miyagawa Y; Akabane T Cancer; 1984 Oct; 54(8):1547-53. PubMed ID: 6332668 [TBL] [Abstract][Full Text] [Related]
12. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. Zipf TF; Fox RI; Dilley J; Levy R Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160 [TBL] [Abstract][Full Text] [Related]
13. A case of chronic lymphocytic leukemia with properties characteristic of natural killer cells. Itoh K; Tsuchikawa K; Awataguchi T; Shiiba K; Kumagai K Blood; 1983 May; 61(5):940-8. PubMed ID: 6187398 [TBL] [Abstract][Full Text] [Related]
14. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Weiss LM; Bindl JM; Picozzi VJ; Link MP; Warnke RA Blood; 1986 Feb; 67(2):474-8. PubMed ID: 3080041 [TBL] [Abstract][Full Text] [Related]
15. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study. Dowell BL; Borowitz MJ; Boyett JM; Pullen DJ; Crist WM; Quddus FF; Russell EC; Falletta JM; Metzgar RS Cancer; 1987 Jun; 59(12):2020-6. PubMed ID: 2952260 [TBL] [Abstract][Full Text] [Related]
16. A human natural killer cell-associated antigen defined by monoclonal antibody anti-Leu (NKP-15): functional and two-color flow cytometry analysis. Lanier LL; Phillips JH; Warner NL; Babcock GF J Leukoc Biol; 1984 Jan; 35(1):11-7. PubMed ID: 6608568 [TBL] [Abstract][Full Text] [Related]
17. Leu 11+ T gamma cell chronic lymphocytic leukemia with partially activated natural killer function and its further activation by recombinant IL2 in vitro. Tagawa S; Tokumine Y; Ueda E; Waki K; Kanayama Y; Taniguchi N; Nakanishi T; Inoue R; Kitani T Blood; 1986 Oct; 68(4):846-52. PubMed ID: 2944554 [TBL] [Abstract][Full Text] [Related]
18. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia. Han T; Ozer H; Minowada J Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920 [TBL] [Abstract][Full Text] [Related]
20. Contribution of immunological markers to the diagnosis and prognosis of human leukemia. von Fliedner V Eur J Cancer Clin Oncol; 1985 Mar; 21(3):347-53. PubMed ID: 3159579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]